Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 08/05/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
12 | |
| 05/12/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
12 | |
| 03/17/09 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
24 | |
| 11/05/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 08/14/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 05/15/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 04/18/08 | EFFECT | Notice of Effectiveness |
|
1 | |
| 04/09/08 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
64 |
